Westchester Capital Management »

Cerevel Therapeutics Hldng I shares owned by Westchester Capital Management

Quarter-by-quarter ownership of Cerevel Therapeutics Hldng I (CERE) shares owned by Westchester Capital Management from 13F filings

Historical chart of Westchester Capital Management investment in Cerevel Therapeutics Hldng I

Tip: Access up to 7 years of quarterly data

All positions including Cerevel Therapeutics Hldng I held by Westchester Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cerevel Therapeutics Hldng I by Westchester Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $39M 929k 42.40

More positions owned by Westchester Capital Management

Pioneer Natural Resources (PXD)
Hess (HES)
stock
Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
Westrock (WRK)
Spirit Rlty Cap Com New
Capri Holdings SHS (CPRI)
United States Steel Corporation Put Option (X)
Endeavor Group Hldgs Cl A Com Put Option (EDR)
Amedisys (AMED)
Sovos Brands
Teck Resources CL B (TECK)
Splunk Note 1.125% 6/1
Albertsons Cos Common Stock (ACI)
Olink Hldg Ab Sponsored Ads (OLK)

View all positions for Westchester Capital Management

Top funds holding Cerevel Therapeutics Hldng I

Perceptive Advisors
venBio Select Advisor
Vanguard Group
Paradigm Biocapital Advisors
Balyasny Asset Management
Alpine Associates Management
Baker Bros. Advisors
Alliancebernstein
Millennium Management
Pentwater Capital Management
CNH Partners
Westchester Capital Management
Voloridge Investment Management
Westfield Capital Management Company
T. Rowe Price Associates

View all funds holding Cerevel Therapeutics Hldng I